These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19375419

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced glucose tolerance in the Brattleboro rat.
    Nakamura K, Yamashita T, Fujiki H, Aoyagi T, Yamauchi J, Mori T, Tanoue A.
    Biochem Biophys Res Commun; 2011 Feb 04; 405(1):64-7. PubMed ID: 21215256
    [Abstract] [Full Text] [Related]

  • 3. Altered lipid metabolism in vasopressin V1B receptor-deficient mice.
    Hiroyama M, Fujiwara Y, Nakamura K, Aoyagi T, Mizutani R, Sanbe A, Tasaki R, Tanoue A.
    Eur J Pharmacol; 2009 Jan 14; 602(2-3):455-61. PubMed ID: 19068213
    [Abstract] [Full Text] [Related]

  • 4. Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor.
    Aoyagi T, Kusakawa S, Sanbe A, Hiroyama M, Fujiwara Y, Yamauchi J, Tanoue A.
    Eur J Pharmacol; 2009 Nov 10; 622(1-3):32-6. PubMed ID: 19766110
    [Abstract] [Full Text] [Related]

  • 5. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice.
    Aoyagi T, Birumachi J, Hiroyama M, Fujiwara Y, Sanbe A, Yamauchi J, Tanoue A.
    Endocrinology; 2007 May 10; 148(5):2075-84. PubMed ID: 17303660
    [Abstract] [Full Text] [Related]

  • 6. Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
    Winzell MS, Magnusson C, Ahrén B.
    Metabolism; 2007 Jan 10; 56(1):122-8. PubMed ID: 17161234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor.
    Itoh S, Yamada S, Mori T, Miwa T, Tottori K, Uwahodo Y, Yamamura Y, Fukuda M, Yamamoto K, Tanoue A, Tsujimoto G.
    Am J Physiol Endocrinol Metab; 2006 Jul 10; 291(1):E147-51. PubMed ID: 16464910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Exercise training attenuates lipectomy-induced impaired glucose tolerance in rats.
    Coelho DF, Gualano B, Artioli GG, Roschel H, Amano M, Benatti FB, Fernandes T, Bueno CR, Câmara NO, Lancha AH.
    Endocr Regul; 2009 Jul 10; 43(3):107-16. PubMed ID: 19817505
    [Abstract] [Full Text] [Related]

  • 11. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice.
    Sainsbury A, Bergen HT, Boey D, Bamming D, Cooney GJ, Lin S, Couzens M, Stroth N, Lee NJ, Lindner D, Singewald N, Karl T, Duffy L, Enriquez R, Slack K, Sperk G, Herzog H.
    Diabetes; 2006 Jan 10; 55(1):19-26. PubMed ID: 16380472
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
    Weisinger RS, Stanley TK, Begg DP, Weisinger HS, Spark KJ, Jois M.
    Physiol Behav; 2009 Aug 04; 98(1-2):192-7. PubMed ID: 19465040
    [Abstract] [Full Text] [Related]

  • 13. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N, Stoev S, Cheng LL, Manning M.
    J Pept Sci; 2006 Mar 04; 12(3):190-8. PubMed ID: 16130178
    [Abstract] [Full Text] [Related]

  • 14. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G.
    J Med Chem; 2004 Apr 22; 47(9):2375-88. PubMed ID: 15084136
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.
    Santos SH, Fernandes LR, Mario EG, Ferreira AV, Pôrto LC, Alvarez-Leite JI, Botion LM, Bader M, Alenina N, Santos RA.
    Diabetes; 2008 Feb 22; 57(2):340-7. PubMed ID: 18025412
    [Abstract] [Full Text] [Related]

  • 18. The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice.
    Yazdi M, Ahnmark A, William-Olsson L, Snaith M, Turner N, Osla F, Wedin M, Asztély AK, Elmgren A, Bohlooly-Y M, Schreyer S, Lindén D.
    Biochem Biophys Res Commun; 2008 May 16; 369(4):1065-70. PubMed ID: 18339309
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
    Nakamura S, Yamamura Y, Itoh S, Hirano T, Tsujimae K, Aoyama M, Kondo K, Ogawa H, Shinohara T, Kan K, Tanada Y, Teramoto S, Sumida T, Nakayama S, Sekiguchi K, Kambe T, Tsujimoto G, Mori T, Tominaga M.
    Br J Pharmacol; 2000 Apr 16; 129(8):1700-6. PubMed ID: 10780976
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.